Skip to main content
. 2019 Dec 10;19(2):1187–1194. doi: 10.3892/ol.2019.11201

Figure 3.

Figure 3.

Comparison of the levels of serum inflammatory factors of the patients in two groups. (A) The level of IL-1β in the propofol group was lower than that in the sevoflurane group. (B) The level of IL-6 in the propofol group was significantly lower than that in the sevoflurane group (P<0.05). (C) The level of IL-10 in the propofol group was lower than that in the sevoflurane group. (D) The level of TNF-α in the propofol group was lower than that in the sevoflurane group. *P<0.05, compared with the sevoflurane group at the same time-point; aP<0.05, compared with the propofol group at 0 min; bP<0.05, compared with the sevoflurane group at 0 min.